GenomeWeb
Publication
- Website
- Last published Sep 8, 2021
Stories
A-Alpha Bio Secures $20M Series A to Advance Yeast-Based Protein Interaction Platform
A-Alpha Bio raised $20 million in Series A funding and will apply its high-throughput yeast-based protein-protein interaction technology to drug discovery through partnerships with Twist Biopharma and Lumen Bioscience.